Superior Genomics is an early-stage mental-health diagnostics company in Norway, Michigan, developing a blood test that distinguishes bipolar disorder from major depressive disorder. The test reads gene-expression bioprofiles detectable in a blood sample, discovered by company physician David Van Holla, and is positioned as the first objective blood-based mental health diagnostic. The company works with Paradise Genomics on the underlying genomic research.